Department of Medicine; Marion Bessin Liver Research Center; Albert Einstein College of Medicine; Bronx, NY USA.
Autophagy. 2013 Aug;9(8):1131-58. doi: 10.4161/auto.25063. Epub 2013 May 22.
Autophagy has emerged as a critical lysosomal pathway that maintains cell function and survival through the degradation of cellular components such as organelles and proteins. Investigations specifically employing the liver or hepatocytes as experimental models have contributed significantly to our current knowledge of autophagic regulation and function. The diverse cellular functions of autophagy, along with unique features of the liver and its principal cell type the hepatocyte, suggest that the liver is highly dependent on autophagy for both normal function and to prevent the development of disease states. However, instances have also been identified in which autophagy promotes pathological changes such as the development of hepatic fibrosis. Considerable evidence has accumulated that alterations in autophagy are an underlying mechanism of a number of common hepatic diseases including toxin-, drug- and ischemia/reperfusion-induced liver injury, fatty liver, viral hepatitis and hepatocellular carcinoma. This review summarizes recent advances in understanding the roles that autophagy plays in normal hepatic physiology and pathophysiology with the intent of furthering the development of autophagy-based therapies for human liver diseases.
自噬已成为一种关键的溶酶体途径,通过降解细胞器和蛋白质等细胞成分来维持细胞功能和生存。专门以肝脏或肝细胞为实验模型的研究,极大地促进了我们对自噬调控和功能的认识。自噬的多种细胞功能,以及肝脏及其主要细胞类型肝细胞的独特特征,表明肝脏对自噬的依赖性很强,不仅对正常功能如此,对预防疾病状态的发生也是如此。然而,也有一些例子表明,自噬会促进病理性变化,如肝纤维化的发展。大量证据表明,自噬的改变是许多常见肝脏疾病的潜在机制,包括毒素、药物和缺血/再灌注诱导的肝损伤、脂肪肝、病毒性肝炎和肝细胞癌。本综述总结了近年来对自噬在正常肝脏生理学和病理生理学中所起作用的理解进展,以期进一步开发基于自噬的人类肝脏疾病治疗方法。